Viewing Study NCT00035633


Ignite Creation Date: 2025-12-25 @ 2:52 AM
Ignite Modification Date: 2026-01-08 @ 6:36 AM
Study NCT ID: NCT00035633
Status: COMPLETED
Last Update Posted: 2011-04-14
First Post: 2002-05-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase III Study of Entecavir vs Lamivudine in Adults With Chronic Hepatitis B Infection and Positive for Hepatitis B E Antigen
Sponsor: Bristol-Myers Squibb
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module